BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 7683136)

  • 1. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
    Yamaguchi S; Baba Y; Naito K
    Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Echo-guided transrectal biopsy. An analysis of the results in a series of 1900 patients].
    Mayayo Dehesa T; Rodríguez-Patrón R; Zuccarino AL; Arias Funez F; Carrera Puerta C; García González R
    Arch Esp Urol; 1999 Jun; 52(5):453-63. PubMed ID: 10427883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
    Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
    Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of prostate biopsy parameters: gland volume and elevated prostate-specific antigen level.
    Rubens DJ; Gottlieb RH; Maldonado CE; Frank IN
    Radiology; 1996 Apr; 199(1):159-63. PubMed ID: 8633140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of cancer of the prostate by determining the blood levels of specific prostatic antigen, rectal examination, and transrectal echography].
    Isa Kroon WA; Robles JE; de Castro F; Rosell D; Abad JI; Zudaire JJ; Berián JM
    Actas Urol Esp; 1993 Jun; 17(6):341-5; discussion 345-6. PubMed ID: 7690176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.
    Beyersdorff D; Taupitz M; Winkelmann B; Fischer T; Lenk S; Loening SA; Hamm B
    Radiology; 2002 Sep; 224(3):701-6. PubMed ID: 12202702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. uPM3, a new molecular urine test for the detection of prostate cancer.
    Fradet Y; Saad F; Aprikian A; Dessureault J; Elhilali M; Trudel C; Mâsse B; Piché L; Chypre C
    Urology; 2004 Aug; 64(2):311-5; discussion 315-6. PubMed ID: 15302485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
    Prestigiacomo AF; Stamey TA
    J Urol; 1997 Jan; 157(1):189-94. PubMed ID: 8976248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.